The U.S. Food and Drug Administration (FDA) has given Pheno Therapeutics the green light to begin clinical testing of PTD802, the company’s oral lead treatment candidate for boosting myelin repair in people with multiple sclerosis (MS) and other neurological diseases. The experimental remyelination therapy aims to potentially…
Discussion
Taking high-dose vitamin D supplements for more than a year can significantly cut relapse risks and ease disability for people with multiple sclerosis (MS), according to a comprehensive review of more than 30 clinical trials. These benefits were observed in patients who added the vitamin to their standard…
Discussion
One of the most exhausting parts of living with multiple sclerosis (MS) isn’t always the symptoms themselves. Sometimes, it’s the constant guessing game. Every ache, twinge, headache, moment of fatigue, or lapse in memory can send me down a mental rabbit hole. Is this MS? Am I experiencing a…
Discussion
Computer-based analyses of microorganisms in the digestive tract can distinguish people with multiple sclerosis (MS) from healthy individuals with high accuracy, according to a new study. The analysis looked beyond gut bacteria to include other organisms like fungi and viruses. The findings suggest these comprehensive microbial profiles could eventually…
Discussion
Tolebrutinib has been approved in the European Union for the treatment of secondary progressive multiple sclerosis (SPMS) for people who have not experienced a relapse in the previous two years. The medication will be sold under the brand name Cenrifki. The decision, which is in line with a…
Get regular updates to your inbox.
